Saniona.com

Saniona.com has Server used 23.100.15.180 IP Address with Hostname in Netherlands. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2014-02-14 (6 years, 286 days) and hosted in Amsterdam Netherlands, server ping response time 98 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Saniona keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Saniona
2 Saniona.com
3 Saniona ab
4 Saniona a/s
5 Saniona avanza
6 Saniona nasdaq
7 Saniona pharma
8 Saniona stock
9 Saniona ticker

Hosting Provider

Website: Saniona.com
Hostname: 23.100.15.180
Country:
Region: 07
City: Amsterdam
Postal Code: 1000
Latitude: 52.349998474121
Longitude: 4.916699886322
Area Code: 0
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Mrt4u.com (3 seconds ago)

   » Carlineautomotive.com (13 seconds ago)

   » Cetaknomorrumah.com (15 seconds ago)

   » Saniona.com (0 seconds ago)

   » Chingum.com (1 seconds ago)

   » Longlakemn.gov (0 seconds ago)

   » Vidfedonline.com (6 seconds ago)

   » Pasco-wa.gov (25 seconds ago)

   » Fontanacuisine.com (7 seconds ago)

   » Lajewelryplaza.com (7 seconds ago)

Results For Websites Listing

Found 69 Websites with content related to this domain, It is result after search with search engine

Saniona

(1 day ago) [email protected] 500 Totten Pond Road (Suite 620) Waltham, MA 02451 USA. Telephone +1-781-839-9100

http://saniona.com/

DA: 11 PA: 11 MOZ Rank: 12

Saniona AB’s Nomination Committee for the Annual General

(14 hours ago) Email: [email protected] information was submitted for publication, through the agency of the contact person set out above, at 16.00 CET on November 26, 2020.About Saniona Saniona is a rare disease biopharmaceutical company focused on research, development and commercialization of treatments for the central nervous system.

https://news.yahoo.com/saniona-ab-nomination-committee-annual-150000276.html

DA: 14 PA: 50 MOZ Rank: 68

Saniona AB’s Nomination Committee for the Annual General

(14 hours ago) PRESS RELEASE. November 26, 2020. Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the composition of the Nomination Committee for the

https://www.globenewswire.com/news-release/2020/11/26/2134699/0/en/Saniona-AB-s-Nomination-Committee-for-the-Annual-General-Meeting-2021.html

DA: 21 PA: 50 MOZ Rank: 50

Saniona Reports Positive Topline Results from Tesomet

(3 day ago) Saniona intends to present and/or publish additional data from this study in an appropriate future peer-reviewed, scientific forum. Additionally, Saniona intends to provide these data to the FDA as part of ongoing communications around plans to ensure that only appropriate patients would receive Tesomet, if approved.

https://www.tmcnet.com/usubmit/2020/11/23/9262989.htm

DA: 14 PA: 31 MOZ Rank: 45

Saniona AB (SANION.ST) Stock Price, News, Quote & History

(3 day ago) About Saniona Saniona is a rare disease biopharmaceutical company focused on research, development and commercialization of treatments for the central nervous system. The company has four programs

https://finance.yahoo.com/quote/SANION.ST/

DA: 17 PA: 17 MOZ Rank: 34

FDA Provides Feedback to Saniona on Development of Tesomet

(1 day ago) The U.S. Food and Drug Administration (FDA) has provided some recommendations to Saniona regarding the development of Tesomet to treat Prader-Willi syndrome (PWS).. In particular, the agency is advising the company to conduct a Phase 3 trial to follow the planned Phase 2b clinical trial, as well as including children younger than 12.. The written feedback from the FDA follows a pre

https://praderwillinews.com/2020/10/13/fda-provides-feedback-saniona-development-tesomet-pws/

DA: 19 PA: 50 MOZ Rank: 85

Saniona to Participate in Oppenheimer’s Virtual 2020 Fall

(1 day ago) Saniona to Participate in Oppenheimer’s Virtual 2020 Fall Healthcare Life Sciences & MedTech Summit. PRESS RELEASE. September 18, 2020. Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that Rami Levin, President and Chief Executive Officer of Saniona, will participate in a virtual fire side chat at the Oppenheimer & Co. Fall

https://tools.eurolandir.com/tools/Pressreleases/GetPressRelease/?ID=3816734&companycode=s-sanion&v=

DA: 20 PA: 37 MOZ Rank: 57

Saniona Reports Positive Topline Results from Tesomet

(3 day ago) Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced positive top-line results from the Phase 2 open-label extension study of Tesomet in

https://markets.businessinsider.com/news/stocks/saniona-reports-positive-topline-results-from-tesomet-phase-2-open-label-extension-study-in-hypothalamic-obesity-1029830520

DA: 27 PA: 50 MOZ Rank: 50

Saniona Reports Positive Topline Results from Tesomet

(3 day ago) Saniona to host webcast with Dr. Ulla Feldt-Rasmussen on Tuesday, 24 November 2020, at 2:00pm ET / 20.00 CET. Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced positive top-line results from the Phase 2 open-label extension study of Tesomet in patients with hypothalamic obesity (HO).

https://tools.eurolandir.com/tools/Pressreleases/GetPressRelease/?ID=3842222&companycode=s-sanion&v=ticker

DA: 20 PA: 37 MOZ Rank: 57

Recently Analyzed Sites